The effect of P2Y12 receptor inhibitors on clinical outcomes in patients with acute coronary syndrome undergoing primary percutaneous intervention and receiving abciximab

BACKGROUND: Our study compared the effect of P2Y12 receptor inhibitors in combination with abciximab on clinical outcomes in patients with acute coronary syndrome (ACS). METHODS: Our study is retrospective, consisting of 852 consecutive ACS patients who presented to our clinic between 2015 and 2021,...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής

Κύριοι συγγραφείς:	Onur Altınkaya, Selim Aydemir, Murat Özmen, Sidar Şiyar Aydın, Emrah Aksakal, Mustafa Özkoç, Rauf Macit, İbrahim Saraç, Yavuzer Koza, Muhammet Hakan Taş
Μορφή:	Artigo
Γλώσσα:	Inglês
Έκδοση:	Via Medica 2025-10-01
Σειρά:	Cardiology Journal
Θέματα:	acute coronary syndrome P2Y12 receptor inhibitors glycoprotein IIB/IIIA inhibitors abciximab bleeding mortality
Διαθέσιμο Online:	https://journals.viamedica.pl/cardiology_journal/article/view/104531
Ετικέτες:	Προσθήκη ετικέτας Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!